Usha Viswanathan is a results-driven computational chemist with nine years of specialized experience in drug discovery, including the past three years at Johnson & Johnson. She possesses expertise in ...
India’s sovereign AI debate is moving from policy ambition to enterprise risk as US model access limits expose gaps in compute, cloud, governance, and infrastructure. If you can only read one tech ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results